BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  More Than 100 Studies From Pfizer Inc.'s Extensive Oncology Portfolio To Be Presented At American Society of Clinical Oncology 2006

  June 2, 2006

   · 

  1 min read
• FDA

  Ranbaxy Pharmaceuticals Inc. Receives Approval To Market Doxycycline Tablets

  June 2, 2006

   · 

  2 min read
• Lone Star Bio

  The Susan G. Komen Breast Cancer Foundation Kicks Off Passionately Pink For The Cure(TM) October 1

  June 2, 2006

   · 

  4 min read
• Biotech Beach

  Tulip BioMed, Inc. Announces Ticker Symbol Change To “PK.TPBD”

  June 2, 2006

   · 

  1 min read
• Lone Star Bio

  Positron Corporation Receives Funding From Private Investment Group

  June 2, 2006

   · 

  1 min read
• Policy

  Akzo Nobel N.V. Menopause Treatment Denied U.S. Approval

  June 2, 2006

   · 

  1 min read
• Pharm Country

  Omrix Biopharmaceuticals, Inc. President And Chief Executive Officer To Ring The NASDAQ Stock Market Opening Bell

  June 2, 2006

   · 

  1 min read
• Pharm Country

  Enzon Pharmaceuticals, Inc. Announces Exercise Of Option To Purchase Additional Convertible Senior Notes

  June 2, 2006

   · 

  1 min read
• Policy

  Paladin Labs Inc. Release: Health Canada Requires Additional Information For GlucaGen’R’ Approval

  June 2, 2006

   · 

  2 min read